News

Surgical instruments being sterilized  (Adobe Stock 325838636 by Senalfred)

A new human factors study reveals the hidden complexity behind sterile processing. Research from the Medical University of South Carolina shows how sterile processing, operating rooms, and courier networks function as one interconnected system. Understanding “work as done” rather than “work as imagined” may be key to improving surgical safety and supporting frontline staff.

Dental Assistant Recognition Week (Adobe Stock 740030692 by Neelrong)

Dental Assistants Recognition Week spotlights the critical role dental assistants play in infection prevention, patient safety, and instrument sterilization. From PPE adherence to surface disinfection and patient education, these professionals manage complex clinical and administrative tasks that protect both patients and dental teams in high-risk aerosol-generating environments. (Entire interview)

Cleaning systems for medical instruments. Ultrasonic cleaner  (Adobe Stock 136854229 By flywish)

When sterile instruments look perfect but hidden soil remains, patient safety is at risk. In this in-depth ICT article, Marjorie Wall, EDBA, CRCST, CIS, CHL, CSSBB, explains why ultrasonic cleaning is not just equipment, but a critical quality system, and how failures in cavitation, lumen flushing, or water quality can quietly undermine infection prevention in the operating room and sterile processing department.

A series of illustrations demonstrating the body’s immune response to sepsis (Adobe Stock 805248810 by Tee with AI)

A multicenter randomized trial of 276 patients with sepsis found that precision immunotherapy targeting immune dysfunction improved organ failure scores by day 9 compared with placebo. Although mortality differences were not statistically significant, the results suggest that biomarker-guided treatment strategies could help personalize sepsis care and improve clinical outcomes.

DNA structure and HIV-infected, blue background  (Adobe Stock 149600914 by Giovanni Cancemi)

Long-acting injectables have transformed HIV management, but viral suppression alone is not enough. Researchers are advancing mRNA vaccines, broadly neutralizing antibodies, latency-reversing agents, pediatric immune strategies, and gene editing to eliminate reservoirs and achieve remission. Here’s how next-generation HIV therapeutics aim to move beyond lifelong ART.

Carol McLay, DrPH, MPH, RN, CIC, FAPIC, FSHEA, the 2025 APIC President

As her 2025 APIC presidency concludes, Carol McLay, DrPH, MPH, RN, CIC, FAPIC, FSHEA, discusses public health funding cuts, science advocacy, global partnerships, workforce development, and why infection preventionists must speak up. In this exclusive ICT interview, she shares lessons from a tumultuous year and her vision for strengthening the infection prevention profession worldwide.

Carol McLay, DrPH, MPH, RN, CIC, FAPIC, FSHEA, the 2025 APIC President

As her 2025 APIC presidency concludes, Carol McLay, DrPH, MPH, RN, CIC, FAPIC, FSHEA, discusses public health funding cuts, science advocacy, global partnerships, workforce development, and why infection preventionists must speak up. In this exclusive ICT interview, she shares lessons from a tumultuous year and her vision for strengthening the infection prevention profession worldwide.

Scientific microscope for using in R&D  (Adobe Stock 526445021 by chokniti)

Before a disinfectant reaches a hospital unit, it undergoes rigorous laboratory testing, formulation science, and regulatory validation. In this ICT Q&A, Candice Taylor, MA, explains how R&D bridges lab efficacy with real-world health care workflow, antimicrobial resistance concerns, and the evolving future of infection prevention technology.

IP LifeLine From Infection Control Today

A national survey of infection preventionists reveals deep concerns about staffing shortages, lack of leadership support, limited authority, and outdated surveillance systems. IP professionals warn that without structural investment, modernization, and executive recognition of their operational value, patient safety, regulatory compliance, and hospital financial stability remain at risk.

Survey special blue banner background  (Adobe Stock 216473756By FR Design)

Infection prevention professionals are weighing in on the CDC’s updated vaccine schedule. An ICT survey reveals mixed familiarity, rising patient questions, and a strong call for clearer guidance and communication tools. Here’s what IPC leaders say about implementation, confidence, and the real-world impact of vaccine policy changes.

February 28 is Rare Disease Day. Ribbon and hand.  (Adobe Stock 1847480273 By juandy)

For Rare Disease Day and Week, ICT presents: Rare autoimmune diseases affect millions worldwide, yet vaccine guidance for these patients remains complex. Understanding disease mechanisms, immunosuppression, and vaccine modalities is critical to reducing infection risk. This article explores practical strategies to guide safe, individualized vaccine decisions in rare autoimmune conditions and protect vulnerable populations.

Detox. Wooden letters on the office desk. (Adobe Stock 190859742 by STOATPHOTO)

Detox is a short but high-risk window for infection. Disrupted sleep, shared spaces, and intensive medication workflows raise exposure pressure. Leading detox programs in San Diego reduce risk with structured intake screening, disciplined medication handling, time-based cleaning, zoning for symptoms, and practical discharge planning that keeps infections from following patients home.

February 28 is Rare Disease Day. Ribbon and hand.  (Adobe Stock 1847480273 By juandy)

At FDA Rare Disease Day 2026, leaders highlighted new regulatory pathways, faster review programs, and patient-centered innovations accelerating treatments for rare diseases, including NF1 and pediatric cancers. From the Plausible Mechanism Framework to expanded real-world evidence use, the message was clear: Urgency, flexibility, and patient voice are driving rare disease drug development forward.